The importance of tamoxifen metabolism in tamoxifen-stimulated breast tumor growth

Cancer Chemotherapy and Pharmacology

Volumn 34, Issue 2, 1994, Pages 89-95

  Osborne, C Kent ^a   Jarman, Michael ^b   McCague, Ray ^b   Coronado, Ester B ^a   Hilsenbeck, Susan G ^a   Wakeling, Alan E ^c  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; DRUG METABOLITE; FULVESTRANT; NAFOXIDINE; TAMOXIFEN; TOREMIFENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DRUG METABOLISM; FEMALE; GROWTH STIMULATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL LINE; TUMOR XENOGRAFT;

ANIMAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COMPARATIVE STUDY; DEPRESSION, CHEMICAL; DISEASE MODELS, ANIMAL; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; ISOMERISM; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; STIMULATION, CHEMICAL; SUPPORT, U.S. GOV'T, P.H.S.; TAMOXIFEN; TUMOR CELLS, CULTURED;

EID: 0028246412     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/BF00685924     Document Type: Article

References (22)

1. Tamoxifen: a reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use
2. Impaired intra-tumoral uptake of tamoxifen as a mechanism for resistance in human breast cancer
3. Systemic treatment of early breast cancer by hormonal, systemic or immune therapy: 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women
4. Measurement of steroid hormone receptors in breast cancer patients on tamoxifen
5. Development of tamoxifen-stimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration
6. Inhibition of tamoxifen-stimulated growth of an MCF-7 tumor variant in athymic mice by novel steroidal antiestrogens
7. Nafoxidine — an antiestrogen for the treatment of breast cancer
8. Synthesis and estrogen receptor binding of 6,7-dihydro-8-phenyl-9-[4-[2-dimethylamino)ethyoxy]phenyl]-5H-benzocycloheptene, a nonisomerizable analogue of tamoxifen. X-ray crystallographic studies
9. Nonisomerizable analogues of (Z)- and (E)-4-hydroxytamoxifen. Synthesis and endocrinological properties of substituted diphenylbenzo-cycloheptenes
10. Structure-function relationships of hydroxylated metabolites of tamoxifen that control the proliferation of estrogen-responsive T47D breast cancer cells in vitro
11. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice
12. Human breast cancer in the athymic nude mouse: cytostatic effects of long-term antiestrogen therapy
13. Acquired tamoxifen resistance: correlation with reduced tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen
14. Tamoxifen and the isomers of 4-hydroxytamoxifen in tamoxifen-resistant tumors from breast cancer patients
15. Tamoxifen antiestrogens. A comparison of the activity, pharmacokinetics, and metabolic activation of the cis and trans isomers of tamoxifen
16. Hormonal treatment of advanced breast cancer
17. Multicenter phase II efficacy trial of toremifene in tamoxifen-refractory patients with advanced breast cancer
18. Effects of antioestrogens on the proliferation of MCF-7 human breast cancer cells
19. A potent specific pure antiestrogen with clinical potential
20. Identification of estrogenic tamoxifen metabolite(s) in tamoxifen resistant human breast tumors
21. Investigation of the mechanism of tamoxifen-stimulated breast tumor growth with nonisomerizable analogues of tamoxifen and metabolites